phenyl acetate has been researched along with Prostatic Neoplasms in 102 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (4.90) | 18.7374 |
1990's | 2 (1.96) | 18.2507 |
2000's | 39 (38.24) | 29.6817 |
2010's | 53 (51.96) | 24.3611 |
2020's | 3 (2.94) | 2.80 |
Authors | Studies |
---|---|
Álvaro-Vegue, C; Carrasco-Muñoz, CG; García-Villa, A; Gomis-Goti, C; Villalba-Cuesta, PL | 1 |
Merseburger, AS; Roesch, MC | 1 |
Attard, G; Brawley, CD; Clarke, CS; Clarke, NW; Cross, W; Dearnaley, DP; Gabrio, A; Gillessen, S; Hunter, RM; Ingleby, FC; James, ND; Jones, RJ; Lester, JF; Malik, Z; Matheson, D; Millman, R; Parker, C; Parmar, MKB; Rush, HL; Russell, JM; Sydes, MR; Wylie, J | 1 |
Andrzejewski, P; Baltzer, PAT; Brader, P; Georg, D; Helbich, TH; Karanikas, G; Margreiter, M; Mitterhauser, M; Pinker, K; Polanec, SH; Stiglbauer, A; Susani, M; Wadsak, W | 1 |
Chen, HM; Chiu, H; Chung, YH; Lin, G; Lin, YC; Lu, KY; Tsai, CK; Wang, CC; Yen, TC | 1 |
Al-Attar, AM; Elkady, AI; Hakeem, KR; Mirza, MB; Mohammed, FA; Syed, FQ | 1 |
Jin, J; Lei, H; Liu, M; Luo, H; Tang, C; Wu, Y; Xu, H; Zhang, J | 1 |
Eredics, K; Friedl, A; Klingler, HC; Knoll, P; Kunit, T; Lusuardi, L; Mirzaei, S; Schneeweiss, J; Sevcenco, S | 1 |
Aime, S; Garello, F; Lanzardo, S; Livio Longo, D; Manfredi, M; Pagoto, A; Porpiglia, F; Stefania, R; Terreno, E; Tripepi, M | 1 |
Axelsson, J; Hashemi, A; Riklund, K; Strandberg, S | 1 |
Tilki, D | 1 |
Andriole, GL; Dehdashti, F; Fischer, KC; Haseebuddin, M; Kibel, AS; Liu, J; Miller, TR; Nepple, KG; Roth, EB; Siegel, BA; Siegel, CL | 1 |
Adler, S; Choyke, P; Kurdziel, K; Lindenberg, L; Mena, E | 1 |
Brogsitter, C; Kotzerke, J; Zöphel, K | 1 |
Babich, JW; Eckelman, WC; Hillier, SM; Joyal, JL; Lu, G; Maresca, KP; Marquis, JC; Merkin, RD; Zimmerman, CN | 1 |
Ali, GR; Giorgio, T; Mohsen, B; Ramin, S; Rasoul, ZS; Reza, DK; Werner, L | 1 |
Kitajima, K; Murphy, RC; Nathan, MA; Sugimura, K | 1 |
Liu, R; Xie, X; Xu, Y; Zhang, Z | 1 |
Allainmat, L; Buchegger, F; Garibotto, V; Jorcano, S; Miralbell, R; Rager, O; Ratib, O; Seimbille, Y; Steiner, C; Vees, H; Zaidi, H; Zilli, T | 1 |
Bu, L; Cheng, K; Cheng, Z; Hu, X; Li, J; Liu, H; Liu, Y; Ma, X; Tian, M; Zhang, H | 1 |
Bischoff, M | 1 |
Andersen, KF; Divilov, V; Koziorowski, J; Lewis, JS; Pillarsetty, N; Sevak, K | 1 |
Bandari, RP; Bassuner, KJ; Bernskoetter, NE; Connors, JP; Hoffman, TJ; Jiang, Z; Kirkpatrick, DL; Reynolds, TS; Rold, TL; Sieckman, GL; Smith, CJ; Szczodroski, AF | 1 |
Bielik, R; Boren, J; Brindle, KM; Larkin, TJ; Lewis, DY; Martins, CP; Neal, DE; Ramos-Montoya, A; Shaw, GL; Soloviev, D | 1 |
Berman-Booty, LD; Clinton, SK; Erdman, JW; Jeffery, EH; Juvik, JA; Liu, AG | 1 |
Hellström, M; Jacobsson, H; Radecka, E; Schumacher, MC; Sundin, A | 1 |
An, GI; Kang, JH; Kim, BS; Kim, CW; Kim, KI; Kim, KM; Kim, MH; Lee, KC; Lee, TS; Lee, YJ; Park, JA; Woo, SK | 1 |
Eiber, M; Frisch, B; Gschwend, JE; Kübler, H; Maurer, T; Navab, N; Okur, A; Schottelius, M; Schwaiger, M; Thalgott, M; Weineisen, M; Weirich, G; Wester, HJ | 1 |
Liu, S; Parajuli, KR; You, Z; Zhang, Q | 1 |
Ahlström, H; Daouacher, G; Gestblom, C; Grzegorek, R; Sörensen, J; von Below, C; Waldén, M; Wassberg, C | 1 |
Dusing, R; Rixey, A; Shah, VA | 1 |
Anner, P; Beheshti, M; Hacker, M; Haug, AR; Karanikas, G; Mitterhauser, M; Polanec, SH; Reiterits, B; Spick, C; Wadsak, W | 1 |
Canovas, C; Denat, F; Goncalves, V; Gourni, E; Maecke, HR; Meyer, PT | 1 |
Eiber, M; Einspieler, I; Maurer, T; Schwaiger, M; Tauber, R | 1 |
Jadvar, H | 2 |
Chen, Z; Guo, G; Liu, J; Liu, L; Wang, D; Wang, T; Zhao, L | 1 |
Cheng, Z; Ding, B; Hong, X; Jiang, Y; Liu, C; Liu, J; Loft, M; Ma, X; Sun, Y; Sun, Z; Xiao, Y; Xu, L; Yang, M; Zhang, Z | 1 |
Czernin, J; Herrmann, K; Spick, C | 1 |
Gianolli, L; Incerti, E; Mapelli, P; Picchio, M | 1 |
Albers, P; Esch, LH; Fahlbusch, M; Hautzel, H; Müller-Mattheis, V | 1 |
Axelsson, J; Karlsson, CT; Ogren, M; Riklund, K; Strandberg, S | 1 |
Buchegger, F; Garibotto, V; Jorcano, S; Lamanna, G; Miralbell, R; Rager, O; Ratib, O; Seimbille, Y; Tabouret-Viaud, C; Vees, HJ; Zaidi, H; Zilli, T | 1 |
Budunova, I; Chatterton, RT; Czwornog, J; Gera, L; Joshi, S; Yemelyanov, A | 1 |
Bozeman, E; Devineni, D; Ezekwudo, D; Palaniappan, R; Selvaraj, P; Shashidharamurthy, R | 1 |
Chan, TH; Chan, WK; Lam, WH; Lee, SC; Lee, TW; Wang, X; Wong, YC | 1 |
Bathina, M; Carper, SW; Elegbede, A; Pierre, KJ; Yeruva, L | 1 |
Bertaccini, A; Borghesi, M; Brunocilla, E; Castellucci, P; Concetti, S; Fanti, S; Farsad, M; Franceschelli, A; Franchi, R; Garofalo, M; Manferrari, F; Martorana, G; Nanni, C; Rocca, C; Sanguedolce, F; Schiavina, R | 1 |
Lindholm, P; Minn, H; Seppänen, M | 1 |
Al-Abed, Y; Basile, F; Biondi, A; Donia, M; Maksimovic-Ivanic, D; Mangano, K; Mijatovic, S; Miljkovic, D; Nicoletti, F; Stosic-Grujicic, S; Tumino, S | 1 |
Larson, SM; Pillarsetty, N; Punzalan, B | 1 |
Arponen, E; Lindholm, P; Minn, H; Seppälä, J; Seppänen, M | 1 |
Blesa, JM; Candel, VA | 1 |
Aiba, Y; Beigelman, L; Blatt, L; Leisvuori, A; Lönnberg, H; Lönnberg, T; Poijärvi-Virta, P | 1 |
Alanen, K; Aronen, HJ; Arponen, E; Borra, R; Dean, K; Jambor, I; Kemppainen, J; Lepomäki, V; Minn, H; Nurmi, M; Parkkola, R | 2 |
Gu, C; Jiang, G; Luo, B; Tao, D; Tong, Q; Wang, L; Xiao, X; Zeng, F; Zhao, J | 1 |
Eary, JF; Hackenbracht, JA; Higano, CS; Link, JM; Mankoff, DA; Montgomery, RB; Muzi, M; Rezvani, BB; Yu, EY | 1 |
Giovannini, E; Messa, C; Picchio, M | 1 |
Emonds, KM; Mortelmans, L; Mottaghy, FM; Nuyts, J; Swinnen, JV; van Weerden, WM; Vanderhoydonc, F | 1 |
Abiraj, K; Cescato, R; Fani, M; Forrer, F; Maecke, HR; Mansi, R; Nicolas, G; Reubi, JC; Tamma, ML | 1 |
Bhalla, P; Budunova, I; Iwadate, K; Karseladze, A; Ugolkov, A; Yang, X; Yemelyanov, A | 1 |
Altai, M; Braun, A; Garske, U; Karlström, AE; Malmberg, J; Orlova, A; Perols, A; Sandström, M; Tolmachev, V; Varasteh, Z | 1 |
Adler, S; Bernardo, M; Choyke, PL; Daar, D; Eclarinal, P; Kurdziel, KA; Kwarteng, G; Lindenberg, ML; Linehan, WM; Mani, H; McKinney, Y; Mena, E; Merino, MJ; Pinto, PA; Pohida, T; Shah, V; Turkbey, B; Valera, VA; Wade, R | 1 |
Dahlbom, M; Huang, SC; Schiepers, C | 1 |
Kato, T | 1 |
Gschwend, JE; Hautmann, RE; Kotzerke, J; Neumaier, B; Reske, SN; Volkmer, BG | 1 |
Kato, T; Katoh, C; Kuge, Y; Nakada, K; Shiga, T; Shinohara, N; Takei, T; Tamaki, N; Tsukamoto, E | 1 |
Engelbach, JA; Jones, LA; Kim, J; Mercer, NM; Oyama, N; Sharp, TL; Welch, MJ | 1 |
Ackermann, R; Coenen, HH; Hautzel, H; Herzog, H; Krause, BJ; Müller-Gärtner, HW; Müller-Mattheis, V; Roden, W | 1 |
Bergh, S; Boerner, AR; Brunkhorst, T; Fricke, E; Hofmann, M; Karstens, JH; Knapp, WH; Machtens, S; Meyer, GJ; van den Hoff, J | 1 |
Glatting, G; Gschwend, JE; Kotzerke, J; Messer, P; Neumaier, B; Reske, SN; van den Hoff, J; Volkmer, BG | 1 |
Andriole, GL; Dehdashti, F; Fischer, KC; Kibel, AS; Michalski, JM; Miller, TR; Oyama, N; Picus, J; Siegel, BA; Welch, MJ | 1 |
Dimitrakopoulou-Strauss, A; Strauss, LG | 1 |
Claessens, F; Hapgood, JP; Louw, A; Rombauts, W; Tanner, TM; Verrijdt, G | 1 |
Gurina, LI; Iudin, SV | 1 |
Biaglow, JE; Chawannakul, D; Hacia, JG; Ho, VV; Karaman, MW; Lecane, P; Lepp, C; Magda, D; Mesfin, M; Miles, D; Miller, RA; Nagpal, S | 1 |
Becherer, A; Djavan, B; Dobrozemsky, G; Dudczak, R; Kletter, K; Kurtaran, A; Li, S; Mitterhauser, M; Pötter, R; Tomek, S; Wachter, S; Wachter-Gerstner, N | 1 |
Häggman, M; Lundin, N; Malmström, PU; Sandblom, G; Sörensen, J | 1 |
Albrecht, S; Bischof Delaloye, A; Buchegger, F; Keller, A; Khan, HG; Miralbell, R; Ratib, O; Soloviev, D; Vees, H; Zaidi, H | 1 |
Akino, H; Aoki, Y; Fujibayashi, Y; Kaneda, T; Matsuta, Y; Miwa, Y; Nakai, M; Okazawa, H; Oyama, N; Shioyama, R; Tanase, K; Yokoyama, O; Yonekura, Y | 1 |
Bansal, A; DeGrado, TR; Hara, T | 1 |
Morris, MJ; Scher, HI | 1 |
Dence, CS; Kim, J; Laforest, R; Oyama, N; Ponde, DE; Siegel, BA; Tai, YC; Welch, MJ | 1 |
Albrecht, S; Buchegger, F; Hany, TF; Husarik, D; Khan, H; Miralbell, R; Soloviev, D; Vees, H; Zaidi, H | 1 |
Brusselmans, K; Claessens, F; Guan, G; Shechter, I; Swinnen, JV; Timmermans, L; Van de Sande, T; Van Veldhoven, PP; Verhoeven, G | 1 |
Funao, K; Hayama, T; Kawahito, Y; Matsuyama, M; Nakatani, T; Sano, H; Takemoto, Y; Yoshimura, R | 1 |
Castellucci, P; Fanti, S; Farsad, M; Nanni, C; Rubello, D | 1 |
Elegbede, JA; Ezekwudo, DE; Wang, RC | 1 |
Dahlbom, M; Hoh, CK; Huang, SC; Nuyts, J; Schiepers, C; Seltzer, M; Wu, C | 1 |
Kridel, SJ; Lewis, JS; Vāvere, AL; Wheeler, FB | 1 |
Al-Nahhas, A; Chierichetti, F; Fini, A; Rubello, D; Soloviev, D | 1 |
Hoffman, TJ; Jurisson, SS; Lane, SR; Rold, TL; Sieckman, GL; Smith, CJ; Veerendra, B | 1 |
Amin, M; Noland, JL | 1 |
Maygarden, SJ; Miyamoto, KK; Mohler, JL; Schiebler, ML; White, M | 1 |
Denef, C; Esquenet, M; Heyns, W; Swinnen, JV; Van Veldhoven, PP; Verhoeven, G | 1 |
Akino, H; Kanamaru, H; Muramoto, S; Okada, K; Oyama, N; Sadato, N; Suzuki, Y; Yamamoto, K; Yonekura, Y | 1 |
Jeffery, SM; Pepe, JJ; Popovich, LM; Vitagliano, G | 1 |
Neumann, F; Steinbeck, H | 1 |
Ablin, RJ | 1 |
Di Silverio, F; Gagliardi, V; Sciarra, F; Sorcini, G | 1 |
Wojewski, A | 1 |
11 review(s) available for phenyl acetate and Prostatic Neoplasms
Article | Year |
---|---|
18F-Choline, 11C-choline and 11C-acetate PET/CT: comparative analysis for imaging prostate cancer patients.
Topics: Acetates; Carbon; Choline; Humans; Male; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Recurrence; Sensitivity and Specificity; Tomography, X-Ray Computed | 2013 |
Application of C-11-acetate positron-emission tomography (PET) imaging in prostate cancer: systematic review and meta-analysis of the literature.
Topics: Acetates; Area Under Curve; Carbon Radioisotopes; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Sensitivity and Specificity; Treatment Outcome | 2013 |
Update on positron emission tomography for imaging of prostate cancer.
Topics: Acetates; Carbon; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2014 |
Positron emission tomography in imaging evaluation of staging, restaging, treatment response, and prognosis in prostate cancer.
Topics: Acetates; Carbon; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
Influence of Four Radiotracers in PET/CT on Diagnostic Accuracy for Prostate Cancer: A Bivariate Random-Effects Meta-Analysis.
Topics: Acetates; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals; ROC Curve | 2016 |
Evaluation of Prostate Cancer with 11C-Acetate PET/CT.
Topics: Acetates; Carbon; Evidence-Based Medicine; Humans; Image Enhancement; Male; Molecular Imaging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
PET imaging for lymph node dissection in prostate cancer.
Topics: Acetates; Carbon Radioisotopes; Carboxylic Acids; Choline; Cyclobutanes; Edetic Acid; Fluorodeoxyglucose F18; Gallium Isotopes; Gallium Radioisotopes; Humans; Lymph Node Excision; Lymph Nodes; Magnetic Resonance Imaging; Male; Multimodal Imaging; Neoplasm Staging; Oligopeptides; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals | 2017 |
Prostate cancer: PET with 18F-FDG, 18F- or 11C-acetate, and 18F- or 11C-choline.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Staging; Prognosis; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2011 |
The role of PET/computed tomography scan in the management of prostate cancer.
Topics: Acetates; Choline; Fluorides; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2011 |
PET imaging of prostate cancer with 11C-acetate.
Topics: Acetates; Carbon; Humans; Male; Neoplasm Recurrence, Local; Prostatic Neoplasms; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
[Anti-androgens. Animal experiments and clinical application].
Topics: Acetates; Androgen Antagonists; Animals; Bone and Bones; Chlormadinone Acetate; Disorders of Sex Development; Dogs; Feedback; Female; Fertility; Humans; Hydroxyprogesterones; Libido; Male; Mice; Progestins; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Rats; Receptors, Drug; Sebaceous Glands; Spermatozoa | 1971 |
12 trial(s) available for phenyl acetate and Prostatic Neoplasms
Article | Year |
---|---|
Cost-utility analysis of adding abiraterone acetate plus prednisone/prednisolone to long-term hormone therapy in newly diagnosed advanced prostate cancer in England: Lifetime decision model based on STAMPEDE trial data.
Topics: Abiraterone Acetate; Acetates; Androgen Antagonists; Cost-Benefit Analysis; Hormones; Humans; Male; Prednisolone; Prednisone; Prostatic Neoplasms; State Medicine | 2022 |
11C-acetate PET/CT before radical prostatectomy: nodal staging and treatment failure prediction.
Topics: Acetates; Aged; Aged, 80 and over; Analysis of Variance; Carbon; Disease-Free Survival; Humans; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Risk; Tomography, X-Ray Computed; Treatment Failure | 2013 |
First imaging results of an intraindividual comparison of (11)C-acetate and (18)F-fluorocholine PET/CT in patients with prostate cancer at early biochemical first or second relapse after prostatectomy or radiotherapy.
Topics: Acetates; Aged; Aged, 80 and over; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Tomography, X-Ray Computed | 2014 |
Functional imaging of localized prostate cancer aggressiveness using 11C-acetate PET/CT and 1H-MR spectroscopy.
Topics: Acetates; Aged; Carbon; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Risk Assessment; Sensitivity and Specificity; Tomography, X-Ray Computed | 2010 |
C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.
Topics: Acetates; Bone Neoplasms; Carbon; Docetaxel; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Taxoids; Treatment Outcome | 2011 |
11C-Acetate PET/CT in localized prostate cancer: a study with MRI and histopathologic correlation.
Topics: Acetates; Adult; Aged; Biological Transport; Biomarkers, Tumor; Carbon; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, X-Ray Computed | 2012 |
Carbon-11 acetate positron emission tomography can detect local recurrence of prostate cancer.
Topics: Acetates; Aged; Aged, 80 and over; Carbon; Feasibility Studies; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Accumulation of [11C]acetate in normal prostate and benign prostatic hyperplasia: comparison with prostate cancer.
Topics: Acetates; Adenocarcinoma; Adult; Age Factors; Aged; Aged, 80 and over; Carbon; Diagnosis, Differential; Humans; Male; Middle Aged; Neoplasms; Organ Specificity; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, Emission-Computed | 2002 |
Positron emission tomography with 11C-acetate and 18F-FDG in prostate cancer patients.
Topics: Acetates; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Fluorodeoxyglucose F18; Humans; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed | 2003 |
11C-acetate PET imaging of prostate cancer: detection of recurrent disease at PSA relapse.
Topics: Acetates; Adenocarcinoma; Aged; Carbon; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Tomography, Emission-Computed | 2003 |
(11)C-acetate PET in the early evaluation of prostate cancer recurrence.
Topics: Acetates; Aged; Carbon; Clinical Trials as Topic; Humans; Image Enhancement; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prognosis; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Treatment Outcome | 2007 |
11C-acetate PET imaging of prostate cancer.
Topics: Acetates; Adenocarcinoma; Aged; Aged, 80 and over; Bone Neoplasms; Carbon; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
79 other study(ies) available for phenyl acetate and Prostatic Neoplasms
Article | Year |
---|---|
Interstitial pneumonitis associated with leuprorelin acetate for a prostate cancer: A case report.
Topics: Acetates; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Humans; Leuprolide; Lung Diseases, Interstitial; Male; Prostatic Neoplasms | 2022 |
Advanced delivery of leuprorelin acetate for the treatment of prostatic cancer.
Topics: Acetates; Androgen Antagonists; Antineoplastic Agents, Hormonal; Humans; Leuprolide; Male; Prostatic Neoplasms | 2022 |
Multiparametric [11C]Acetate positron emission tomography-magnetic resonance imaging in the assessment and staging of prostate cancer.
Topics: Acetates; Aged; Aged, 80 and over; Carbon Radioisotopes; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2017 |
Early Response Monitoring Following Radiation Therapy by Using [
Topics: Acetates; Animals; Blotting, Western; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Spectroscopy; Male; Metabolome; Metabolomics; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Reproducibility of Results; Xenograft Model Antitumor Assays | 2017 |
Induction of apoptosis and cell cycle arrest by ethyl acetate fraction of Phoenix dactylifera L. (Ajwa dates) in prostate cancer cells.
Topics: Acetates; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Cycle Checkpoints; Cell Line, Tumor; DNA Fragmentation; Humans; Male; Membrane Potential, Mitochondrial; Oxidative Stress; Phoeniceae; Plant Extracts; Prostatic Neoplasms; Solvents | 2018 |
Montelukast inhibits hypoxia inducible factor-1α translation in prostate cancer cells.
Topics: Acetates; Cell Line, Tumor; Cell Proliferation; Cyclopropanes; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Prostatic Neoplasms; Protein Biosynthesis; Proteolysis; Quinolines; Receptors, Leukotriene; Sulfides | 2018 |
Application of Cu-64 NODAGA-PSMA PET in Prostate Cancer.
Topics: Acetates; Aged; Aged, 80 and over; Antigens, Surface; Copper Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Male; Middle Aged; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies | 2018 |
An efficient MRI agent targeting extracellular markers in prostate adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Animals; Azepines; Biomarkers, Tumor; Cell Line, Tumor; Contrast Media; Fibrin; Fibronectins; Gadolinium; Humans; Magnetic Resonance Imaging; Male; Mice; Mice, Nude; Neoplasm Transplantation; Peptides; Prostatic Neoplasms; Protein Binding; Spectrometry, Mass, Electrospray Ionization | 2019 |
Optimization of PET reconstruction algorithm, SUV thresholding algorithm and PET acquisition time in clinical 11C-acetate PET/CT.
Topics: Acetates; Aged; Aged, 80 and over; Algorithms; Biological Transport; Carbon Radioisotopes; Humans; Image Processing, Computer-Assisted; Lymph Nodes; Male; Middle Aged; Phantoms, Imaging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Risk; Time Factors | 2018 |
Editorial Comment.
Topics: Acetates; Humans; Lymph Nodes; Male; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2019 |
Reply: To PMID 22343504.
Topics: Acetates; Carbon; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2013 |
99mTc-labeled small-molecule inhibitors of prostate-specific membrane antigen for molecular imaging of prostate cancer.
Topics: Acetates; Animals; Antigens, Surface; Biological Transport; Cell Line, Tumor; Chelating Agents; Glutamate Carboxypeptidase II; Glutamic Acid; Humans; Lysine; Male; Mice; Molecular Imaging; Organotechnetium Compounds; Prostatic Neoplasms; Protease Inhibitors; Radiochemistry; Radionuclide Imaging; Technetium; Urea | 2013 |
A retrospective study of prostate cancer cases mimicking urothelial cell carcinoma of the bladder.
Topics: Acetates; Aged; Aged, 80 and over; Carbon Radioisotopes; Diagnosis, Differential; Follow-Up Studies; Humans; Male; Middle Aged; Positron-Emission Tomography; Prostatic Neoplasms; Retrospective Studies; Tomography, X-Ray Computed; Ultrasonography, Doppler, Color; Urinary Bladder Neoplasms; Urothelium | 2013 |
A comparative study of radiolabeled bombesin analogs for the PET imaging of prostate cancer.
Topics: Acetates; Animals; Bombesin; Cell Line, Tumor; Cell Transformation, Neoplastic; Copper Radioisotopes; Drug Stability; Fluorine Radioisotopes; Heterocyclic Compounds, 1-Ring; Isotope Labeling; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Radiochemistry | 2013 |
[Prostate cancer staging: ¹ ¹ C-Acetat-PET/CT as a sensitive marker for nodal metastases].
Topics: Acetates; Carbon; Humans; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Tomography, X-Ray Computed | 2013 |
Influence of free fatty acids on glucose uptake in prostate cancer cells.
Topics: Acetates; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Fatty Acids, Nonesterified; Fluorodeoxyglucose F18; Glucose; Humans; Male; Prostatic Neoplasms | 2014 |
Synthesis and biological evaluation of copper-64 radiolabeled [DUPA-6-Ahx-(NODAGA)-5-Ava-BBN(7-14)NH2], a novel bivalent targeting vector having affinity for two distinct biomarkers (GRPr/PSMA) of prostate cancer.
Topics: Acetates; Amino Acids, Neutral; Aminocaproic Acid; Animals; Antigens, Surface; Biological Transport; Biomarkers, Tumor; Bombesin; Cell Line, Tumor; Chemistry Techniques, Synthetic; Copper Radioisotopes; Female; Glutamate Carboxypeptidase II; Glutarates; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Protein Binding; Radiochemistry; Receptors, Bombesin; Urea | 2014 |
Late Imaging with [1-(11)C]Acetate Improves Detection of Tumor Fatty Acid Synthesis with PET.
Topics: Acetates; Animals; Carbon Radioisotopes; Fatty Acids; Lung Neoplasms; Male; Mice; Positron-Emission Tomography; Prostatic Neoplasms; Time Factors; Tomography, X-Ray Computed | 2014 |
Enhancement of broccoli indole glucosinolates by methyl jasmonate treatment and effects on prostate carcinogenesis.
Topics: Acetates; Animals; Brassica; Carcinogenesis; Cyclopentanes; Glucosinolates; Indoles; Male; Mice, Inbred C57BL; Oxylipins; Plant Extracts; Plant Growth Regulators; Prostatic Neoplasms | 2014 |
[11C]Acetate positron emission tomography-computed tomography imaging of prostate cancer lymph-node metastases correlated with histopathological findings after extended lymphadenectomy.
Topics: Acetates; Aged; Carbon Radioisotopes; Cohort Studies; Humans; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Positron-Emission Tomography; Prospective Studies; Prostate; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, X-Ray Computed | 2015 |
Evaluation of a ⁶⁴Cu‑labeled 1,4,7‑triazacyclononane, 1‑glutaric acid‑4,7 acetic acid (NODAGA)‑galactose‑bombesin analogue as a PET imaging probe in a gastrin‑releasing peptide receptor‑expressing prostate cancer xenograft model.
Topics: Acetates; Animals; Bombesin; Cell Line, Tumor; Copper Radioisotopes; Female; Galactose; Heterocyclic Compounds, 1-Ring; Heterografts; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Positron-Emission Tomography; Prostatic Neoplasms; Receptors, Bombesin | 2015 |
Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer.
Topics: Acetates; Adenocarcinoma; Aged; Cohort Studies; Edetic Acid; Ethylenediamines; Feasibility Studies; Gallium Isotopes; Gallium Radioisotopes; Humans; Kallikreins; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Oligopeptides; Organometallic Compounds; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatic Neoplasms; Surgery, Computer-Assisted | 2015 |
Aminomethylphosphonic acid and methoxyacetic acid induce apoptosis in prostate cancer cells.
Topics: Acetates; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Cycle; Cell Line, Tumor; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Isoxazoles; Male; Organophosphonates; Prostate; Prostatic Neoplasms; Tetrazoles | 2015 |
Laparoscopic extended pelvic lymph node (LN) dissection as validation of the performance of [(11) C]-acetate positron emission tomography/computer tomography in the detection of LN metastasis in intermediate- and high-risk prostate cancer.
Topics: Acetates; Aged; Carbon; Humans; Laparoscopy; Lymph Node Excision; Lymph Nodes; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostatic Neoplasms; Radiopharmaceuticals; Risk Assessment | 2016 |
Prostate Cancer Metastases to Inguinal Lymph Nodes Detected by Attenuation-Corrected 11C-Acetate PET/CT.
Topics: Acetates; Carbon; Humans; Image Processing, Computer-Assisted; Lymphatic Metastasis; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms | 2016 |
Detection of Bone Metastases Using 11C-Acetate PET in Patients with Prostate Cancer with Biochemical Recurrence.
Topics: Acetates; Bone Neoplasms; Carbon; Female; Humans; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Retrospective Studies | 2015 |
(R)-NODAGA-PSMA: A Versatile Precursor for Radiometal Labeling and Nuclear Imaging of PSMA-Positive Tumors.
Topics: Acetates; Animals; Antigens, Surface; Female; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Heterocyclic Compounds, 1-Ring; Humans; Image Processing, Computer-Assisted; Male; Mice; Mice, Inbred BALB C; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2015 |
68Ga Prostate-Specific Membrane Antigen Uptake in Renal Cell Cancer Lymph Node Metastases.
Topics: Acetates; Aged; Antigens, Surface; Carcinoma, Renal Cell; Ethylenediamines; Gallium Radioisotopes; Glutamate Carboxypeptidase II; Humans; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2016 |
Preclinical Study on GRPR-Targeted (68)Ga-Probes for PET Imaging of Prostate Cancer.
Topics: Acetates; Animals; Biological Transport; Cell Line, Tumor; Drug Stability; Gallium Radioisotopes; Heterocyclic Compounds, 1-Ring; Humans; Male; Mice; Octanols; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Receptors, Bombesin; Tissue Distribution; Water | 2016 |
11C-acetate positron-emission tomography/computed tomography imaging for detection of recurrent disease after radical prostatectomy or radiotherapy in patients with prostate cancer.
Topics: Acetates; Aged; Carbon Radioisotopes; Humans; Male; Middle Aged; Positron Emission Tomography Computed Tomography; Prospective Studies; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2017 |
11C-Acetate-PET/CT Compared to 99mTc-HDP Bone Scintigraphy in Primary Staging of High-risk Prostate Cancer.
Topics: Acetates; Aged; Aged, 80 and over; Humans; Male; Middle Aged; Multimodal Imaging; Neoplasm Staging; Organotechnetium Compounds; Positron-Emission Tomography; Prostatic Neoplasms; Risk Factors; Tomography, X-Ray Computed | 2016 |
Long-term Results of a Comparative PET/CT and PET/MRI Study of 11C-Acetate and 18F-Fluorocholine for Restaging of Early Recurrent Prostate Cancer.
Topics: Acetates; Aged; Carbon; Choline; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron Emission Tomography Computed Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2017 |
Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells.
Topics: Acetates; Androgen Antagonists; Androgens; Apoptosis; Blotting, Western; Cell Proliferation; Colony-Forming Units Assay; Electrophoretic Mobility Shift Assay; Ethylamines; Humans; Hydrogen Bonding; Luciferases; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Radioligand Assay; Receptors, Androgen; Receptors, Glucocorticoid; RNA, Small Interfering; Transcription Factors; Transcription, Genetic; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Tyramine | 2008 |
Inhibition of expression of anti-apoptotic protein Bcl-2 and induction of cell death in radioresistant human prostate adenocarcinoma cell line (PC-3) by methyl jasmonate.
Topics: Acetates; Adenocarcinoma; Annexin A5; Apoptosis; Caspase 3; Cell Death; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Dose-Response Relationship, Drug; Down-Regulation; Gamma Rays; Humans; Male; Oxylipins; Prostatic Neoplasms; Proto-Oncogene Proteins c-bcl-2; Radiation Tolerance; Radiation-Sensitizing Agents | 2008 |
Effect of a prodrug of the green tea polyphenol (-)-epigallocatechin-3-gallate on the growth of androgen-independent prostate cancer in vivo.
Topics: Acetates; Androgens; Animals; Apoptosis; Biological Availability; Catechin; Cell Division; Humans; Immunohistochemistry; Ki-67 Antigen; Male; Mice; Mice, Nude; Neoplasm Transplantation; Neovascularization, Pathologic; Prodrugs; Proliferating Cell Nuclear Antigen; Prostate-Specific Antigen; Prostatic Neoplasms; Tea; Transplantation, Heterologous | 2008 |
Delayed cytotoxic effects of methyl jasmonate and cis-jasmone induced apoptosis in prostate cancer cells.
Topics: Acetates; Antineoplastic Agents, Phytogenic; Apoptosis; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclopentanes; Humans; Male; Oxylipins; Prostatic Neoplasms; Receptors, Tumor Necrosis Factor, Type I | 2008 |
Positron-emission tomography in imaging and staging prostate cancer.
Topics: Acetates; Aged; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2008 |
The role of PET/CT and current challenges in prostate cancer management.
Topics: Acetates; Bone Neoplasms; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tomography, X-Ray Computed | 2009 |
The novel NO-donating compound GIT-27NO inhibits in vivo growth of human prostate cancer cells and prevents murine immunoinflammatory hepatitis.
Topics: Acetates; Animals; Antineoplastic Agents; Cell Line, Tumor; Cell Survival; Concanavalin A; Female; Hepatitis, Autoimmune; Humans; In Vitro Techniques; Male; Mice; Mice, Inbred Strains; Mice, Nude; Neoplasm Transplantation; Nitric Oxide Donors; Oxazoles; Prostatic Neoplasms; Transplantation, Heterologous | 2009 |
2-18F-Fluoropropionic acid as a PET imaging agent for prostate cancer.
Topics: Acetates; Animals; Carbon Radioisotopes; Fluorocarbons; Male; Mice; Octanols; Positron-Emission Tomography; Propionates; Prostatic Neoplasms; Radioactive Tracers; Tissue Distribution; Water | 2009 |
Carbon-11 acetate PET/CT based dose escalated IMRT in prostate cancer.
Topics: Acetates; Carbon; Carbon Radioisotopes; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiotherapy Dosage; Radiotherapy, Intensity-Modulated; Tomography, X-Ray Computed | 2009 |
PSA decrease with fulvestrant acetate in a hormone-resistant metastatic prostate cancer patient.
Topics: Acetates; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Bone Neoplasms; Compassionate Use Trials; Disease Progression; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Neoplasm; Drugs, Investigational; Estradiol; Fulvestrant; Humans; Injections, Intramuscular; Male; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Retreatment | 2010 |
Chemical and enzymatic stability of amino acid derived phosphoramidates of antiviral nucleoside 5'-monophosphates bearing a biodegradable protecting group.
Topics: Acetates; Alanine; Amides; Animals; Antiviral Agents; Cytidine Monophosphate; Enzyme Stability; Esterases; Humans; Kinetics; Liver; Male; Malonates; Molecular Structure; Phosphoric Acids; Prostatic Neoplasms; Ribavirin; Swine; Time Factors | 2010 |
AN N-terminal Smac peptide sensitizes human prostate carcinoma cells to methyl jasmonate-induced apoptosis.
Topics: Acetates; Amino Acid Sequence; Apoptosis; Blotting, Western; Caspase 3; Caspase 9; Cell Line; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclopentanes; Dose-Response Relationship, Drug; Down-Regulation; Drug Synergism; Humans; Inhibitor of Apoptosis Proteins; Male; Oligopeptides; Oxylipins; Prostatic Neoplasms; Signal Transduction; X-Linked Inhibitor of Apoptosis Protein | 2011 |
Do androgens control the uptake of 18F-FDG, 11C-choline and 11C-acetate in human prostate cancer cell lines?
Topics: Acetates; Androgens; Biological Transport; Carbon Radioisotopes; Cell Line, Tumor; Choline; Fluorodeoxyglucose F18; Humans; Male; Neoplasm Staging; Prostatic Neoplasms | 2011 |
Bombesin antagonist-based radioligands for translational nuclear imaging of gastrin-releasing peptide receptor-positive tumors.
Topics: Acetates; Amino Acid Sequence; Animals; Bombesin; Calcium; Cell Line, Tumor; Diagnostic Imaging; HEK293 Cells; Heterocyclic Compounds, 1-Ring; Humans; Ligands; Male; Mice; Multimodal Imaging; Oligopeptides; Polyethylene Glycols; Positron-Emission Tomography; Prostatic Neoplasms; Radiochemistry; Receptors, Bombesin; Tomography, X-Ray Computed; Translational Research, Biomedical | 2011 |
Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality.
Topics: Acetates; Adult; Aged; Aged, 80 and over; Androgen Receptor Antagonists; Antineoplastic Agents; Apoptosis; Boronic Acids; Bortezomib; Carcinoma; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Endoplasmic Reticulum Chaperone BiP; Endoplasmic Reticulum Stress; Gene Expression Regulation, Neoplastic; Humans; Male; Middle Aged; Prostatic Neoplasms; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Protein Stability; Pyrazines; Receptors, Androgen; Receptors, Glucocorticoid; Transcription Factor CHOP; Transcriptional Activation; Tyramine | 2012 |
Comparative evaluation of synthetic anti-HER2 Affibody molecules site-specifically labelled with 111In using N-terminal DOTA, NOTA and NODAGA chelators in mice bearing prostate cancer xenografts.
Topics: Acetates; Amino Acid Sequence; Animals; Antibodies, Monoclonal; Binding Sites; Cell Line, Tumor; Cell Transformation, Neoplastic; Chelating Agents; Gene Expression Regulation, Neoplastic; Heterocyclic Compounds; Heterocyclic Compounds, 1-Ring; Humans; Indium Radioisotopes; Isotope Labeling; Male; Mice; Molecular Imaging; Molecular Sequence Data; Prostatic Neoplasms; Receptor, ErbB-2; Substrate Specificity | 2012 |
Improved detection of localized prostate cancer using co-registered MRI and 11C-acetate PET/CT.
Topics: Acetates; Aged; Carbon; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Subtraction Technique; Tomography, X-Ray Computed | 2012 |
Dynamic PET/CT with 11C-acetate in prostate cancer.
Topics: Acetates; Carbon; Humans; Magnetic Resonance Imaging; Male; Multimodal Imaging; Positron-Emission Tomography; Prostatic Neoplasms; Tomography, X-Ray Computed | 2013 |
[Evaluation of physiological accumulation of [11C]acetate in normal prostate using positron emission tomography].
Topics: Acetates; Adult; Aged; Aged, 80 and over; Carbon Radioisotopes; Diagnosis, Differential; Evaluation Studies as Topic; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Prostate; Prostatic Neoplasms; Tomography, Emission-Computed | 2002 |
MicroPET assessment of androgenic control of glucose and acetate uptake in the rat prostate and a prostate cancer tumor model.
Topics: Acetates; Androgen Antagonists; Androgens; Animals; Carbon; Diethylstilbestrol; Dihydrotestosterone; Disease Models, Animal; Fluorodeoxyglucose F18; Humans; Injections, Intraperitoneal; Injections, Subcutaneous; Male; Mice; Mice, Nude; Neoplasm Transplantation; Organ Specificity; Prostate; Prostatic Neoplasms; Radiopharmaceuticals; Rats; Tissue Distribution; Tomography, Emission-Computed | 2002 |
[The (11C) acetate positron emission tomography in prostatic carcinoma. New prospects in metabolic imaging].
Topics: Acetates; Adenocarcinoma; Amino Acids; Biopsy; Carbon Radioisotopes; Choline; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prostate; Prostatic Neoplasms; Sensitivity and Specificity; Tomography, Emission-Computed | 2002 |
Intraindividual comparison of [11C]acetate and [11C]choline PET for detection of metastases of prostate cancer.
Topics: Acetates; Aged; Aged, 80 and over; Biological Transport; Biopsy; Carbon Radioisotopes; Choline; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatic Neoplasms; Reference Values; Tissue Distribution; Tomography, Emission-Computed; Ultrasonography | 2003 |
Anti-androgenic properties of Compound A, an analog of a non-steroidal plant compound.
Topics: Acetates; Androgen Antagonists; Androgens; Animals; Binding Sites; Cells, Cultured; DNA; Ethylamines; Gene Expression Regulation; Genes, Reporter; Haplorhini; Histone Acetyltransferases; Humans; Ligands; Male; Nuclear Receptor Coactivator 1; Plants; Promoter Regions, Genetic; Prostate-Specific Antigen; Prostatic Neoplasms; Protein Structure, Tertiary; Receptors, Androgen; Transcription Factors; Transcription, Genetic; Transfection; Tyramine | 2003 |
[Experience with therapy of prostate cancer in the Primorye Territory].
Topics: Acetates; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents, Hormonal; Flutamide; Gynecomastia; Humans; Male; Middle Aged; Penile Erection; Prostatic Neoplasms; Russia; Treatment Outcome | 2004 |
Motexafin gadolinium disrupts zinc metabolism in human cancer cell lines.
Topics: Acetates; Antineoplastic Agents; Cadmium; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Gene Expression; Gene Expression Profiling; Humans; Lung Neoplasms; Lymphoma, B-Cell; Male; Metalloporphyrins; Neoplasms; Oxidation-Reduction; Prostatic Neoplasms; Thioctic Acid; Zinc; Zinc Acetate | 2005 |
11C-acetate positron emission tomography imaging and image fusion with computed tomography and magnetic resonance imaging in patients with recurrent prostate cancer.
Topics: Acetates; Adenocarcinoma; Aged; Aged, 80 and over; Carbon Radioisotopes; Feasibility Studies; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatectomy; Prostatic Neoplasms; Retrospective Studies; Tomography, X-Ray Computed | 2006 |
Positron emission tomography with C11-acetate for tumor detection and localization in patients with prostate-specific antigen relapse after radical prostatectomy.
Topics: Acetates; Aged; Biomarkers, Tumor; Carbon; Carbon Radioisotopes; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Pilot Projects; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms | 2006 |
[Pet imaging in prostate cancer].
Topics: Acetates; Bone and Bones; Bone Neoplasms; Carbon Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals | 2006 |
Effect of hypoxia on the uptake of [methyl-3H]choline, [1-14C] acetate and [18F]FDG in cultured prostate cancer cells.
Topics: Acetates; Adenosine Triphosphate; Carbon Radioisotopes; Cell Count; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Choline; Dihydrotestosterone; Fluorodeoxyglucose F18; Humans; Male; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tritium | 2006 |
(11)C-acetate PET imaging in prostate cancer.
Topics: Acetates; Carbon; Clinical Trials as Topic; Humans; Image Enhancement; Lymphatic Metastasis; Male; Neoplasm Recurrence, Local; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Sensitivity and Specificity | 2007 |
18F-fluoroacetate: a potential acetate analog for prostate tumor imaging--in vivo evaluation of 18F-fluoroacetate versus 11C-acetate.
Topics: Acetates; Animals; Carbon Radioisotopes; Chromatography, High Pressure Liquid; Fluorine Radioisotopes; Fluoroacetates; Male; Papio; Positron-Emission Tomography; Prostatic Neoplasms; Rats; Rats, Sprague-Dawley; Tissue Distribution | 2007 |
18F-choline and/or 11C-acetate positron emission tomography: detection of residual or progressive subclinical disease at very low prostate-specific antigen values (<1 ng/mL) after radical prostatectomy.
Topics: Acetates; Aged; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm, Residual; Positron-Emission Tomography; Prostate-Specific Antigen; Prostatectomy; Prostatic Neoplasms; Radiopharmaceuticals; Salvage Therapy; Tomography, X-Ray Computed; Treatment Outcome | 2007 |
Squalene synthase, a determinant of Raft-associated cholesterol and modulator of cancer cell proliferation.
Topics: Acetates; Androgens; Bridged Bicyclo Compounds, Heterocyclic; Carbon Radioisotopes; Cell Death; Cell Division; Cell Line, Tumor; Cholesterol; Detergents; Enzyme Inhibitors; Farnesyl-Diphosphate Farnesyltransferase; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Humans; Male; Membrane Microdomains; Promoter Regions, Genetic; Prostatic Neoplasms; RNA, Messenger; RNA, Small Interfering; Sterol Regulatory Element Binding Proteins; Terpenes; Tricarboxylic Acids | 2007 |
Overexpression of cysteinyl LT1 receptor in prostate cancer and CysLT1R antagonist inhibits prostate cancer cell growth through apoptosis.
Topics: Acetates; Aged; Apoptosis; Cell Proliferation; Cyclopropanes; Disease Progression; Flow Cytometry; Gene Expression Regulation, Neoplastic; Humans; Immunoenzyme Techniques; Leukotriene Antagonists; Male; Membrane Proteins; Middle Aged; Prostate; Prostatic Hyperplasia; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Quinolines; Receptors, Leukotriene; Sulfides; Tumor Cells, Cultured | 2007 |
11C/ 18F-choline PET or 11C/18F-acetate PET in prostate cancer: may a choice be recommended?
Topics: Acetates; Carbon Radioisotopes; Choline; Fluorine Radioisotopes; Humans; Image Enhancement; Male; Positron-Emission Tomography; Practice Guidelines as Topic; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2007 |
Methyl jasmonate induced apoptosis in human prostate carcinoma cells via 5-lipoxygenase dependent pathway.
Topics: Acetates; Anticarcinogenic Agents; Apoptosis; Arachidonate 5-Lipoxygenase; Cell Cycle; Cell Line, Tumor; Cyclopentanes; Humans; Male; Oxylipins; Prostatic Neoplasms | 2007 |
1-11C-acetate kinetics of prostate cancer.
Topics: Acetates; Aged; Carbon; Computer Simulation; Humans; Image Interpretation, Computer-Assisted; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Models, Biological; Prostatic Neoplasms; Radionuclide Imaging; Radiopharmaceuticals | 2008 |
1-11C-acetate as a PET radiopharmaceutical for imaging fatty acid synthase expression in prostate cancer.
Topics: Acetates; Animals; Biomarkers, Tumor; Carbon; Fatty Acid Synthases; Gene Expression Profiling; Male; Metabolic Clearance Rate; Mice; Neoplasm Proteins; Organ Specificity; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Tissue Distribution | 2008 |
PET imaging with 11C-acetate in prostate cancer: a biochemical, radiochemical and clinical perspective.
Topics: Acetates; Carbon; Diagnosis, Differential; Humans; Male; Neoplasm Staging; Positron-Emission Tomography; Prostatic Neoplasms; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity | 2008 |
99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptor.
Topics: Acetates; Acetic Acid; Animals; Binding, Competitive; Bombesin; Carrier Proteins; Cations, Monovalent; Cell Line, Tumor; Chelating Agents; Disease Models, Animal; Female; Humans; Isotope Labeling; Male; Mice; Mice, SCID; Neoplasm Transplantation; Organotechnetium Compounds; Polyamines; Prostatic Neoplasms; Protein Binding; Radionuclide Imaging; Radiopharmaceuticals; Receptors, Bombesin; Spectrometry, Mass, Electrospray Ionization; Technetium | 2008 |
Diethylstilbestrol di-trimethylacetate (DSTMA). A long-acting estrogen.
Topics: Acetates; Acid Phosphatase; Adenocarcinoma; Aged; Alkaline Phosphatase; Animals; Carcinoma; Diethylstilbestrol; Dogs; Esters; Estradiol; Humans; Male; Middle Aged; Prostatic Neoplasms; Rats; Structure-Activity Relationship | 1980 |
In vitro high resolution 1H-spectroscopy of the human prostate: benign prostatic hyperplasia, normal peripheral zone and adenocarcinoma.
Topics: Acetates; Adenocarcinoma; Citrates; Glutamates; Humans; Hydrogen; Inositol; Lactates; Magnetic Resonance Spectroscopy; Male; N-Acetylneuraminic Acid; Prostate; Prostatic Hyperplasia; Prostatic Neoplasms; Sialic Acids | 1993 |
Retinoids stimulate lipid synthesis and accumulation in LNCaP prostatic adenocarcinoma cells.
Topics: Acetates; Adenocarcinoma; Azo Compounds; Calcitriol; Coloring Agents; Fatty Acid Synthases; Humans; Hydroxymethylglutaryl CoA Reductases; Lipids; Male; Metribolone; Prostatic Neoplasms; RNA, Messenger; Testosterone Congeners; Tretinoin; Triiodothyronine; Tumor Cells, Cultured | 1997 |
Gabapentin for hot flashes in prostate cancer.
Topics: Acetates; Aged; Amines; Androgen Antagonists; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Antagonists; Gabapentin; gamma-Aminobutyric Acid; Gonadotropin-Releasing Hormone; Hot Flashes; Humans; Male; Prostatic Neoplasms | 2002 |
Immunological surveillance and -globulin.
Topics: Acetates; Adenocarcinoma; Alpha-Globulins; Cellulose; Cryosurgery; Electrophoresis; gamma-Globulins; Humans; Male; Neoplasm Metastasis; Prostatic Neoplasms | 1973 |
[In vitro biosynthesis of androgens in testis of subjects with prostatic cancer treated with estrogens and cyproterone acetate].
Topics: 17-Hydroxycorticosteroids; Acetates; Adult; Aged; Androgen Antagonists; Androgens; Androstanes; Dehydroepiandrosterone; Diethylstilbestrol; Humans; Ketones; Male; Middle Aged; Pregnanes; Prostatic Neoplasms; Radioimmunoassay; Testosterone | 1970 |
[Personal reflections on cancer of the prostate].
Topics: 17-Ketosteroids; Acetates; Acid Phosphatase; Adenocarcinoma; Adenoma, Islet Cell; Adult; Aged; Biopsy; Blood Sedimentation; Estrogens; Hematuria; Humans; Male; Middle Aged; Neoplasm Metastasis; Prostatectomy; Prostatic Neoplasms; Radionuclide Imaging; Rectum; Urinary Incontinence | 1968 |